Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1989-07-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-291X(89)92385-1PMID 2527034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cloning and expression of the staphylokinase gene of Staphylococcus aureus in Escherichia coli

  2004cited by this paper
• Overproduction of staphylokinase in Escherichia coli and its characterization.

  1985cited by this paper
• Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – I. Fibrinolytic and Fibrinogenolytic Properties in Human Plasma In Vitro of Urokinases Obtained from Human Urine or by Recombinant DNA Technology

  1984cited by this paper
• Nucleotide sequence of the staphylokinase gene from Staphylococcus aureus.

  1983cited by this paper
• Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus

  1981cited by this paper
• Comparison of the Relative Fibrinogenolytic, Fibrinolytic and Thrombolytic Properties of Tissue Plasminogen Activator and Urokinase in Vitro

  1981cited by this paper
• Kinetic properties of the primary inhibitor of plasmin from human plasma.

  1977cited by this paper
• The activation by staphylokinase of human plasminogen.

  1975cited by this paper
• Staphylokinase: an Activator of Plasma Protease

  1948cited by this paper

• Strategies for the Discovery and Design of Tissue Plasminogen Activators: Insights Into Bioengineering Objectives

  2025cites this paper
• Thrombolytic Enzymes of Microbial Origin: A Review

  2021cites this paper
• Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion

  2019cites this paper
• Structural Biology and Protein Engineering of Thrombolytics

  2019cites this paper
• Staphylokinase: A Potent Thrombolytic Agent

  2018cites this paper
• New insights into the role of Plg-RKT in macrophage recruitment.

  2014cites this paper
• STAPHYLOKINASE: A BOON IN MEDICAL SCIENCES – REVIEW

  2013cites this paper
• Serine‐proteases as plasminogen activators in terms of fibrinolysis

  2012cites this paper
• Intermolecular interactions in staphylokinase–plasmin(ogen) bimolecular complex: Function of His43 and Tyr44

  2011cites this paper
• A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue‐type plasminogen activator

  2011cites this paper
• Effect of staphylokinase-derived nonadecapeptide on the activation of plasminogen

  2007cites this paper
• Development of new fibrinolytic agents.

  2006cites this paper
• COMMENTARY: An ideal thrombolytic and antithrombotic agent?

  2005cites this paper
• Thrombolysis: Scientific Basis for Current Therapy

  2005cites this paper
• Enhanced plasminogen activation by staphylokinase in the presence of streptokinase β/βγ domains: Plasminogen kringles play a role

  2005cites this paper
• Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role.

  2005cites this paper
• Brief Rapid Communication Coronary Thrombolysis With Recombinant Staphylokinase in Patients With Evolving Myocardial Infarction

  2005cites this paper
• α Domain Deletion Converts Streptokinase into a Fibrin-dependent Plasminogen Activator through Mechanisms Akin to Staphylokinase and Tissue Plasminogen Activator*

  2004cites this paper
• Complex interactions between bovine plasminogen and streptococcal plasminogen activator PauA.

  2004cites this paper
• alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.

  2004cites this paper
• Human Plasminogen: Structure, Activation, and Function

  2003cites this paper
• Basic and Clinical Aspects of Fibrinolysis and Thrombolysis

  2003cites this paper
• Chimerism Reveals a Role for the Streptokinase β-Domain in Nonproteolytic Active Site Formation, Substrate, and Inhibitor Interactions*

  2002cites this paper
• Enhanced Thrombolysis Induced by Argatroban or Activated Protein C in the Presence or Absence of Staphylokinase, Measured in an in vivo Animal Model Using Mesenteric Arterioles

  2001cites this paper
• The Mechanism of a Bacterial Plasminogen Activator Intermediate between Streptokinase and Staphylokinase*

  2001cites this paper
• Plasminogen and Streptokinase

  2001cites this paper
• Analysis of plasminogen activation by the plasmin–staphylokinase complex in plasma of α2-antiplasmin-deficient mice

  2000cites this paper
• Enhancement of Secretion and Extracellular Stability of Staphylokinase in Bacillus subtilis bywprA Gene Disruption

  2000cites this paper
• Use of the plasminogen activation system by microorganisms.

  1999cites this paper
• [Staphylokinase and its mutants: a new generation of thrombolytic agents].

  1998cites this paper
• High level secretion of recombinant staphylokinase into periplasm of Escherichia coli

  1998cites this paper
• Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent

  1998cites this paper
• Induction conditions for maximizing recombinant staphylokinase expression in Escherichia coli

  1997cites this paper
• Molecular Regulation of Fibrinolysis

  1997cites this paper
• Adjuvant effect of argatroban on staphylokinase induced thrombolysis of platelet rich thrombi in rat mesenteric venules in vivo.

  1997cites this paper
• Crystallization and preliminary X‐Ray analysis of recombinant staphylokinase

  1997cites this paper
• Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci.

  1996cites this paper
• Effects of endothelial cells on activity of staphylokinase.

  1996cites this paper
• Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.

  1996cites this paper
• Fibrinolytic properties of staphylokinase mutants obtained by ‘clustered charge-to-alanine’ mutagenesis*

  1996cites this paper
• Staphylokinase, a fibrin-specific bacterial plasminogen activator

  1996cites this paper
• Crystallization and preliminary X-ray diffraction studies of recombinant staphylokinase.

  1996cites this paper
• Structure-Function Relationships in Staphylokinase as Revealed by "Clustered Charge to Alanine" Mutagenesis (*)

  1995cites this paper
• Interactions of Staphylokinase with Human Platelets

  1995cites this paper
• Differential Inhibition with Antifibrinolytic Agents of Staphylokinase and Streptokinase Induced Clot Lysis

  1995influential citation
• Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.

  1994cites this paper
• Characterization of the interaction between plasminogen and staphylokinase.

  1994cites this paper
• Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.

  1994cites this paper
• Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.

  1994cites this paper
• Fibrin-specific fibrinolysis induced by recombinant staphylokinase.

  1994cites this paper
• Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?

  1994cites this paper
• Involvement of protease inhibitors in staphylokinase-induced fibrin-specific fibrinolysis.

  1994cites this paper
• Effects of α2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex

  1994cites this paper
• Novel thrombolytic agents

  1994cites this paper
• High Yield Production and Purification of Recombinant Staphylokinase for Thrombolytic Therapy

  1994cites this paper
• Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.

  1994cites this paper
• Measurement of staphylokinase by enzyme-linked immunosorbent assay using monoclonal antibodies.

  1994cites this paper
• Functional Properties of p-Anisoylated Plasmin-Staphylokinase Complex

  1993cites this paper
• Coronary Thrombolysis With Recombinant Staphylokinase in Patients With Evolving Myocardial Infarction

  1993cites this paper
• Inhibitory Effect of Staphylokinase on Platelet Aggregation

  1993cites this paper
• Interaction of staphylokinase with different molecular forms of plasminogen.

  1993cites this paper
• Isolation and conditioning of recombinant staphylokinase for use in man

  1993cites this paper
• Effect of Plasminogen Activator on Platelet Aggregation

  1993cites this paper
• Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.

  1993cites this paper
• A thrombosis model for evaluating thrombolytic agents in the guinea‐pig: comparison of t‐PA, scu‐PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity

  1993cites this paper
• Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.

  1993cites this paper
• Molecular Conversions of Recombinant Staphylokinase During Plasminogen Activation in Purified Systems and in Human Plasma

  1993influential citation
• Physical and conformational properties of staphylokinase in solution.

  1993cites this paper
• Bio-Immunoassay for Staphylokinase in Blood

  1993cites this paper
• On the molecular interactions between plasminogen-staphylokinase, α2-antiplasmin-formula> and fibrin

  1992cites this paper
• Biochemical-properties of natural and recombinant staphylokinase

  1992cites this paper
• On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.

  1992cites this paper
• Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro

  1992cites this paper
• Isolation and characterisation of natural and recombinant staphylokinase

  1992cites this paper
• On the mechanism of fibrin-specific plasminogen activation by staphylokinase.

  1991cites this paper
• Basic and clinical aspects of fibrinolysis and thrombolysis.

  1991cites this paper
• Basic and Clinical Aspects of Fibrinolysis and Thrombolysis

  1991cites this paper
• Comparative Fibrinolytic Properties of Staphylokinase and Streptokinase in Animal Models of Venous Thrombosis

  1991cites this paper